1Novak N, Kwiek B, Bieber T. The mode of topical immunomodulators in the immunological network of atopic dermatitis[J]. Clin Exp Dermatol, 2005, 30(1):160- 164.
2Marzia C, Daniele T, Emiliano A, et al. The effects of tacrolimus ointment on regulatory T lymphocytes in Atopic Dermatitis[J]. J Clin Immunol, 2006, 26(4):370-375.
4Bekersky I, Fitzsimmons W, Tanase A, et al. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis [J]. J Am Acad Dematol, 2001, 44(1 suppl):S17-27.
5Andris R, Rim G, Nora V, et al. Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis[J]. J Invest Dermatol, 2005, 125(1):68-71.
6Ruzicka T, Bieber T, Schopf E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European tacrolimus multicenter atopic dermatitis study group[J]. N Engl J Med,1997, 337(12):816-821.
7Boguniewicz M, Fiedler VC, Raimer S, et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children.pediatric tacrolimus study group [J]. J Allergy Clin Immunol, 1998, 102(4 pt 1):637-644.
8Soter NA, Fleischer AB Jr, Webster GF, et al.Tacrolimus ointemt for the treatment of atopic dermatitis in adult patients: part Ⅱ, safety [J]. J Am Acad Dermatol, 2001, 44(1 suppl):S39-46.
9Reitamo S, Wollenberg A, Schopf E, et al. Safety and efficacy of 1 year of tacrolimus ointment monothempy in adults with atopic dermatitis. The European tacrolimus ointment study group [J]. Arch Dermatol,2000, 136(8):999-1006.
10Paller A, Eichenfield LF, Leung DY, et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients[J]. J Am Acad Dematol,2001, 44(1 suppl):S47-57.
2Hanifin JM, Ling MR, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy[J]. J Am Acad Dermatol, 2001, 44(1 Suppl): S28-38.
3Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis[J]. J Clin Invest, 2004, 113(5): 651-657.
4Soter NA, Fleischer AB Jr, Webster GF, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part Ⅱ, safety[J]. J Am Acad Dermatol, 2001, 44(1 Suppl): S39-46.
5Kang S, Lucky AW, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children[J]. J Am Acad Dermatol, 2001, 44(1 Suppl): S58-64.
6Hanifin JM, Ling MR, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adultpatients: part Ⅰ, efficacy. J Am Acad Dermatol, 2001, 44(1 Suppl): S28-S38.
7Soter NA, Fleischer AB Jr, Webster GF, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part Ⅱ, safety.J Am Acad Dermatol, 2001, 44(1 Suppl): S39-S46.
8Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol, 1994, 131:383-396.
9Rajka G, Langeland T. Grading of the severity of atopic dermatitis.Acta Derm Venereol Suppl (Stockh), 1989, 144: 13-14.
10Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.EASI Evaluator Group. Exp Dermatol, 2001, 10:11-18.
